Evaluation of the roles of the A185C and C406T kinesin light-chain 1 variants in the development of leukoaraiosis

Neuroscience Letters

Volumn 429, Issue 2-3, 2007, Pages 101-104

  Szolnoki, Zoltan ^a   Kondacs, Andras ^a   Mandi, Yvette ^b   Somogyvari, Ferenc ^b  

^a Pandy Kalman Bekes County Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cytoskeleton; Genetic variants; Kinesin; Leukoaraiosis; White matter hyperintensity

Indexed keywords

CYTOSKELETON PROTEIN; KINESIN LIGHT CHAIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOSKELETON; DEMENTIA; DEMYELINATION; ENHANCER REGION; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; LEUKOARAIOSIS; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIORITY JOURNAL; PROTEIN VARIANT; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WHITE MATTER;

5' UNTRANSLATED REGIONS; AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; CYTOSKELETON; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INTRONS; LEUKOARAIOSIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; SMOKING; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 36349019684     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.09.069     Document Type: Article

References (28)

1. Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., and Itoyama Y. Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke 26 (1995) 1478-1489
2. Amar K., Macgowan S., Wilcock G., Lewis T., and Scott M. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population. Int. J. Geriatr. Psychiatry 13 (1998) 585-590
3. Basile A.M., Pantoni L., Pracucci G., Asplund K., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Hennerici M., O'Brien J., Scheltens P., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Inzitari D., and LADIS Study Group. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc. Dis. 2 (2006) 315-322
4. Dhaenens C.M., Van Brussel E., Schraen-Maschke S., Pasquier F., Delacourte A., and Sablonniere B. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci. Lett. 368 (2004) 290-292
5. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., and Zimmermann R.A. MRI signal abnormalities at 1.5T in Alzeimer's dementia and normal aging. Am. J. Roentgenol. 149 (1987) 351-356
6. Hachinski V.C., Potter P., and Merskey H. Leuko-araiosis: an ancient term for a new problem. Can. J. Neurol. Sci. 13 (1986) 533-534
7. Inzitari D., Simoni M., Pracucci G., Poggesi A., Basile A.M., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Hennerici M., O'Brien P., Barkhof F., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Pantoni L., and LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch. Intern. Med. 167 (2007) 81-88
8. Junque C., Pujol L., Vendrell P., Bruna O., Jodar M., Ribas J.C., Vinas J., Capdevila A., and Marti-Vilalta J.L. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch. Neurol. 47 (1990) 151-156
9. Khan U., Porteous L., Hassan A., and Markus H. Risk factor profile of cerebral small vessel disease and its subtypes. J. Neurol. Neurosurg. Psychiatry 78 (2007) 702-706
10. Liu C.K., Miller B.L., Cummings J.L., Mehringer C.M., Goldberg M.A., Howng S.L., and Benson D.F. A quantitative MRI study of vascular dementia. Neurology 42 (1992) 138-143
11. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215-1218
12. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc. Dis. 13 (2002) 7-14
13. Pantoni L., and Garcia J.H. Pathogenesis of leukoaraiosis, a review. Stroke 28 (1997) 652-659
14. Pantoni L., Poggesi A., Basile A.M., Pracucci G., Barkhof F., Chabriat H., Erkinjuntti T., Ferro J.M., Hennerici M., O'Brien P., Schmidt R., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Inzitari D., and LADIS Study Group. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J. Am. Geriatr. Soc. 54 (2006) 95-101
15. Sawada H., Udaka F., Izumi Y., Nishinaka K., Kawakami H., Nakamura S., and Kameyama M. Cerebral white matter lesions are not associated with ApoE genotype but with age and female sex in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 68 (2000) 653-666
16. Schmidt H., Fazekas F., Kostner G.M., van Duijn C.M.C., and Schmidt R. Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke 32 (2001) 405-412
17. Schmidt R., Schmidt H., Fazekas F., Schumacher M., Niederkom K., Kapeller P., Weinrauch V., and Kostner G.M. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 28 (1997) 951-956
18. Schmidt R., Schmidt H., Fazekas F., Kapeller P., Roob G., Lechner A., Kostner G.M., and Hartung H.P. MRI cerebral white matter lesions and paraoxonase PON1 polymophism: three-year follow-up of the Austrian Stroke Prevention Study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1811-1816
19. Steingart A., Hachinski V.C., Lau C., Fox A.J., Diaz F., Cape R., Lee D., Inzitari D., and Merskey H. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch. Neurol. 44 (1987) 32-35
20. Steingart A., Hachinski V.C., Lau C., Fox A.J., Lee D., Inzitari D., and Merskey H. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch. Neurol. 44 (1987) 36-39
21. Szolnoki Z. Chemical events behind leukoaraiosis: medicinal chemistry offers a new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype). Curr. Med. Chem. 14 (2007) 1027-1236
22. Szolnoki Z. Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromol. Med. 9 (2007) 21-33
23. Szolnoki Z., Kondacs A., Mandi Y., and Somogyvari F. A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization. J Mol Neurosci. 33 2 (2007) 173-179
24. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., and Fodor L. Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol. Scand. 104 (2001) 281-287
25. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., Fodor L., Bene J., and Melegh B. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol. Scand. 109 (2004) 222-227
26. van Gijn J. Leukoaraiosis and vascular dementia. Neurology 51 (1998) 3-8
27. Yao H., Sadoshima S., Ibayashi S., Kuwabara Y., Ichiya Y., and Fujishima M. Leukoaraiosis and dementia in hypertensive patients. Stroke 23 (1992) 1673-1677
28. Ylikoski R., Ylikoski A., Erkinjuntti T., Sulkava R., Raininko R., and Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch. Neurol. 50 (1993) 818-824